Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Oxurion breidt zijn capaciteiten uit om in te spelen op de groeiende vraag naar…
Leuven, BELGIË – 2 juni 2026 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een bedrijf dat zich specialiseert in het verwerven van meerderheidsbelangen in veelbelovende Europese farmaceutische onderaannemers, kondigt vandaag de lancering aan van een toegewijd dienstenaanbod gericht op GLP-1-therapieën, peptidetherapeutica en ontwikkelingsprogramma's voor biosimilars…
Actusnews Wire
02/06/2026
Oxurion expands its capabilities to address the growing demand for GLP-1 and…
Leuven, BELGIUM – June 2, 2026 – 18:00 PM CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company based in Leuven, today announced the launch of a dedicated service offering focused on GLP-1 therapies, peptide therapeutics and biosimilar development programs. Through its subsidiary Axiodis, the Group now offers specialized…
Actusnews Wire
02/06/2026
OXURION : Stopzetting van de besprekingen over het Franse CRO-project (LOI van…
Leuven, BELGIË – 1 juni 2026 – 18u30 CET Oxurion NV (Euronext Brussel: OXUR), een biofarmaceutisch bedrijf gevestigd te Leuven, kondigt aan dat het de besprekingen heeft stopgezet met betrekking tot de voorgenomen verwerving van een meerderheidsparticipatie in een Franse Contract Research Organization (CRO)…
Actusnews Wire
02/06/2026
Oxurion - Termination of discussions for the French CRO project (LOI dated…
Leuven, BELGIUM – June 1st, 2026 – 18:30 PM CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company based in Leuven, today announces the termination of discussions regarding the proposed acquisition of a majority stake in a French Contract Research Organization (CRO). This transaction was initially disclosed on October 13, 2025, and…
Actusnews Wire
02/06/2026
BASTIDE : Completion of the disposal of New Medical Concept, the holding company…
Caissargues, 1st June 2026 – Bastide Group announces the completion of the acquisition by Sapio Group of its subsidiary New Medical Concept, the holding company of the French EXPERF Group, a specialist in home infusion and clinical nutrition care. The sale agreement was signed on May 21, 2026, and all conditions precedent were fulfilled by the end…
Actusnews Wire
01/06/2026
DMS GROUP RECEIVES EUR 4 MILLION FROM THE EUROPEAN INVESTMENT BANK, 1ST DRAWDOWN…
DMS GROUP RECEIVES €4 MILLION FROM THE EUROPEAN INVESTMENT BANK, 1ST DRAWDOWN OF THE TOTAL FINANCING OF €20 MILLION A long-term European institutional funding to accelerate the development of the next generation of medical imaging Issuance of share subscription warrants (BSA) for the benefit of the EIB with a maturity of 14 years June 1st, 2026 –…
Actusnews Wire
01/06/2026
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II…
Leuven, BELGIUM – May 29, 2026 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notifications as follows: Oxurion received a transparency notification on May 27, 2026, from Atlas Special Opportunities II, LLC…
Actusnews Wire
29/05/2026
OXURION : Information on the Total Number of Voting Rights (Denominator)…
Atlas Special Opportunities, LLC has converted 3 convertible bonds in Oxurion resulting in a EUR 75,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital Commitment[1]. Leuven, BELGIUM – May 27 2026 – 06:00 PM CET – In accordance with article 15 of the Belgian Act of May 2, 2007 on the disclosure of major…
Actusnews Wire
27/05/2026
Oxurion Receives Transparency Notification from Atlas Special Opportunities II…
Leuven, BELGIUM – May 26, 2026 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows: Oxurion received a transparency notification on May 22, 2026, from Atlas Special Opportunities II, LLC…
Actusnews Wire
26/05/2026
Groupe Bastide sells New Medical Concept, the holding company of EXPERF group -…
Caissargues, 21 May 2026 – Groupe Bastide today announced the signing of an agreement for the disposal of its subsidiary New Medical Concept, the holding company of the French group EXPERF, specialized in home infusion and clinical nutrition care, to Sapio Group. The previous press release published on the same day contains an error regarding the…
Actusnews Wire
21/05/2026
Groupe Bastide sells New Medical Concept, the holding company of EXPERF group -…
Caissargues, 21 May 2026 –Groupe Bastide today announced the signing of an agreement for the disposal of its subsidiary New Medical Concept, the holding company of the French group EXPERF, specialized in home infusion and clinical nutrition care, to Sapio Group. The previous press release published on the same day contains an error regarding the…
Actusnews Wire
21/05/2026
Groupe Bastide sells New Medical Concept, the holding company of EXPERF group
Caissargues, 21 May 2026 –Groupe Bastide today announced the signing of an agreement for the disposal of its subsidiary New Medical Concept, the holding company of the French group EXPERF, specialized in home infusion and clinical nutrition care, to Sapio Group. Since its acquisition in 2017, EXPERF has delivered sustained growth, with revenue more…
Actusnews Wire
21/05/2026
BASTIDE : Strong momentum for the first nine months of the financial year: up…
Sustained growth in home healthcare services: up 8.5% Solid growth of 5.2% in Homecare, including the one-off impact of the VPH* reform in the third quarter 2025-2026 targets confirmed Caissargues, May 13, 2026 – Groupe Bastide, a leading European provider of home healthcare services, has published its revenue for third-quarter 2025-2026…
Actusnews Wire
13/05/2026
Women for Progress 2026: in Salento (Italy) the young women who are changing the…
Associazione Culturale In Progress
09/05/2026
Oxurion Receives Transparency Notification from Atlas Special Opportunities II…
Leuven, BELGIUM – May 5, 2026 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows: Oxurion received a transparency notification on May 4, 2026, from Atlas Special Opportunities II, LLC…
Actusnews Wire
05/05/2026
OXURION : Publication Annual Report - Annual Shareholders Meeting
Leuven, BELGIUM – April 30, 2026 – 18:30 PM CET - Oxurion NV (Euronext Brussels: OXUR), a pharmaceutical outsourcing company based in Leuven, has today published its annual report for the financial year 2025. The annual report for the year ending December 31, 2025 is available in the “Investors” section of the Company's website and can also be…
Actusnews Wire
30/04/2026
THERANEXUS : THX Pharma Publishes Its 2025 Annual Results, Cash Position as of…
Lyon, France – April 28, 2026 – 7:00 p.m. CEST – THX Pharma (Theranexus), an innovative biopharmaceutical company specializing in the treatment of rare neurological diseases, today announces its annual results as of December 31, 2025, its cash position as of March 31, 2026, and provides a business update…
Actusnews Wire
28/04/2026
LUMIBIRD: Q1 REVENUE UP +0.7% AND +4.1% AT CONSTANT EXCHANGE RATES
Lannion, 27 April 2026– 5:45 pm Q1 revenue up +0.7% and +4.1% at constant exchange rates The LUMIBIRD Group (FR0000038242 - LBIRD), the European leader in laser technologies, reported a 0.7% increase (+4.1% at constant exchange rates and scope) in its consolidated revenue for the first quarter of 2026, reaching €49.7 million…
Actusnews Wire
27/04/2026
Klea Holding reports record results in 2025 and demonstrates remarkable…
Annual revenue growth of 28%, to €22.2 million. 57% increase in EBITDA and normalized EBITDA, representing a margin of 31%. Operating income doubled to €3.4 million. Net income attributable to the Group positive for the second consecutive year at €2.3 million. Cash position of over €5 million and net financial debt close to zero…
Actusnews Wire
23/04/2026
DMS GROUP : Q1 2026 REVENUE: EUR 10 MILLION
Q1 2026 REVENUE: €10 MILLION Cyclical slowdown in activity in Q1 2026 - Recovery in growth expected in Q2 2026 Confirmation of the annual outlook: outperforming the medical imaging market by achieving another year of growth in activity in a market temporarily impacted by the global context April 21, 2026 – 5:45 pm – Diagnostic Medical Systems…
Actusnews Wire
21/04/2026
Oxurion Receives Transparency Notification from Atlas Special Opportunities II…
Leuven, BELGIUM – April 16, 2026 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows: Oxurion received a transparency notification on April 16, 2026, from Atlas Special Opportunities II…
Actusnews Wire
16/04/2026
DMS GROUP : FURTHER STRONG GROWTH IN ANNUAL RESULTS FOR THE 2025 FINANCIAL YEAR
FURTHER STRONG GROWTH IN ANNUAL RESULTS FOR THE 2025 FINANCIAL YEAR Solid growth in activity of +8.5% in 2025 to €50 million, driven by sustained international development and the North American market Dynamic EBITDA growth of +69% - EBITDA margin of 9.1% (vs. 5.9%), of which 11.0% in H2 2025 +€2.8 million improvement in net income, now positive…
Actusnews Wire
14/04/2026
LUMIBIRD MEDICAL ACCELERATES ASIA PACIFIC EXPANSION WITH FUTURE ACQUISITION OF…
Lannion, 8 April 2026 – 5:45 pm LUMIBIRD MEDICAL ACCELERATES ASIA PACIFIC EXPANSION WITH FUTURE ACQUISITION OF BIZ MEDIC SDN BHD TO FORM NEW SOUTHEAST ASIAN HUB The LUMIBIRD Group (FR0000038242 – LBIRD), the European leader in laser technologies, announces that its subsidiary Lumibird Medical has signed an agreement to acquire its long-term…
Actusnews Wire
08/04/2026
DMS GROUP OBTAINS EUROPEAN MDR CERTIFICATION FOR ITS STRATOS BONE DENSITOMETER…
April 7, 2026 – 6:00 pm – Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 – ALDMS), a specialist in high-performance medical imaging systems for digital radiology and bone densitometry, announces that it has obtained MDR (Medical Device Regulation – Regulation (EU) 2017/745) certification for its entire range of bone densitometers, STRATOS and STRATOS DR…
Actusnews Wire
07/04/2026
Altri Comunicati
